Study title: Eformoterol versus salmeterol: reduction in short acting bronchodilator usage in asthmatic children treated with inhaled steroids: FACT.
| Type of medicine: Medicines containing chemical active substances | |||||
| Therapeutic area: Respiratory Tract Diseases | |||||
| Brands: | |||||
| MAH holders: Please see report, Please see report | |||||
| Assessment: | |||||
| Active substance: FORMOTEROL | |||||
| ATC code: R03AC13 | |||||
| Document link: BU-037-0004 Study Synopsis.pdf | |||||
| Document date: 2011-11-22 | |||||
| Study number: BU-037-CR-0004 | |||||
| EudraCT number: | |||||
| Scope of study: Clinical | |||||
| Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
| - | - | - | - | - | |